OVARIANCANCER

Clinical trials for OVARIANCANCER explained in plain language.

Never miss a new study

Get alerted when new OVARIANCANCER trials appear

Sign up with your email to follow new studies for OVARIANCANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to shrink ovarian tumors in Hard-to-Treat patients

Disease control Not yet recruiting

This phase 2 trial tests two oral drugs, zeprumetostat and fuzuloparib, in 30 people with advanced or recurrent ovarian cancer who do not have BRCA gene mutations. The goal is to see if the combination can shrink tumors and delay progression. Participants first take fuzuloparib a…

Matched conditions: OVARIANCANCER

Phase: PHASE2 • Sponsor: Peking University Third Hospital • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

OVARIANCANCER

Get alerted when new OVARIANCANCER trials appear

New drug combo aims to shrink ovarian tumors in Hard-to-Treat patients